Childhood Hodgkin Lymphoma in Sub-Saharan Africa: A Systematic Review on the Effectiveness of the Use of Chemotherapy Alone
- PMID: 38188077
- PMCID: PMC10771044
- DOI: 10.1177/2333794X231223266
Childhood Hodgkin Lymphoma in Sub-Saharan Africa: A Systematic Review on the Effectiveness of the Use of Chemotherapy Alone
Abstract
Introduction. Childhood Hodgkin lymphoma (HL) is often curable, but in Sub-Saharan Africa (SSA), access to standard treatments like combined chemotherapy and radiotherapy is limited. This study aimed at evaluating the effectiveness of using chemotherapy alone for children with HL in SSA. Methods. We searched Medline, Embase, Cinahl Plus and Cochrane Central databases for records of studies that evaluated childhood HL survival outcomes from January 2000 to December 2022. Results. Six observational studies were identified for inclusion, and 3 were included in the meta-analysis. Most HL cases included in the analysis presented with lymphadenopathy and the nodular sclerosing subtype, with a high percentage (80%) in advanced stages. The GRADE certainty of the evidence for the assessed outcomes was rated as very low. Overall survival with chemotherapy was 67.8% (95% CI: 42.1%-88.8%). Conclusion. Chemotherapy is a potential treatment choice for childhood HL in SSA. However, it is crucial to approach this option cautiously due to the limited certainty of the supporting evidence. To improve outcomes for affected children in SSA, more robust studies are needed, along with a focus on early detection and supportive care.
Keywords: Hodgkin lymphoma; SubSaharan Africa; chemotherapy; hematology/oncology.
© The Author(s) 2024.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Integrated community case management of childhood illness in low- and middle-income countries.Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD012882. doi: 10.1002/14651858.CD012882.pub2. Cochrane Database Syst Rev. 2021. PMID: 33565123 Free PMC article.
-
Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration.Ann Hematol. 2019 Feb;98(2):381-389. doi: 10.1007/s00277-018-3533-0. Epub 2018 Nov 5. Ann Hematol. 2019. PMID: 30397846 Clinical Trial.
-
Childhood Pneumonia Diagnostics in Sub-Saharan Africa: A Systematic Review.J Trop Pediatr. 2022 Jun 6;68(4):fmac045. doi: 10.1093/tropej/fmac045. J Trop Pediatr. 2022. PMID: 35674266
-
Survival pattern of colorectal cancer in Sub-Saharan Africa: A systematic review and meta-analysis.Cancer Epidemiol. 2022 Dec;81:102276. doi: 10.1016/j.canep.2022.102276. Epub 2022 Oct 17. Cancer Epidemiol. 2022. PMID: 36257176 Review.
-
The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.Pan Afr Med J. 2021 Mar 26;38:308. doi: 10.11604/pamj.2021.38.308.26014. eCollection 2021. Pan Afr Med J. 2021. PMID: 34178226 Free PMC article.
Cited by
-
Pediatric Hodgkin Lymphoma in Low- and Middle-Income Countries (LMICs). A Narrative Review.Mediterr J Hematol Infect Dis. 2024 Nov 1;16(1):e2024078. doi: 10.4084/MJHID.2024.078. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 39534707 Free PMC article. Review.
-
Risk-Stratified and Response-Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience.Adv Hematol. 2025 Jul 26;2025:5453729. doi: 10.1155/ah/5453729. eCollection 2025. Adv Hematol. 2025. PMID: 40755951 Free PMC article.
-
Lymphadenopathies: A Retrospective Study of Epidemiology, Characteristics, Diagnosis and Treatment Outcomes of Patients in a Tertiary Hospital in Mogadishu-Somalia.Infect Drug Resist. 2025 Jan 30;18:557-566. doi: 10.2147/IDR.S488617. eCollection 2025. Infect Drug Resist. 2025. PMID: 39902271 Free PMC article.
References
-
- Mayo Clinic. Hodgkin’s Lymphoma (Hodgkin’s Disease). Mayo Foundation for Medical Education and Research. Published 2022. Accessed May 13, 2022. https://www.mayoclinic.org/diseases-conditions/hodgkins-lymphoma/symptom...
-
- Institute NC. Childhood Hodgkin Lymphoma Treatment. National Cancer Institute. Published 2022. Accessed May 9, 2022. https://www.cancer.gov/types/lymphoma/patient/child-hodgkin-treatment-pd...
-
- Traore F, Akonde FBD, Togo B, et al.. Treatment of childhood Hodgkin lymphoma in sub-Saharan Africa: a report from the French-African Paediatric Oncology Group (GFAOP). S Afr J Child Health. 2020;14:155.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials